Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (261-270 of 599) with videos related to

Pageof 60
Sort By:
Experimental Neurology|April 15, 2020
Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic strokePranay Srivastava, Chunxia G Cronin, Victoria L Scranton, et al.
Purinergic Signalling|June 6, 2008
Synthesis and pharmacological characterization of [(125)I]MRS1898, a high-affinity, selective radioligand for the rat A(3) adenosine receptorZhan-Guo Gao, Bao Teng, Haitao Wu, et al.
Biochemical Pharmacology|August 31, 2006
Uridine-5'-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarctSmadar Yitzhaki, Asher Shainberg, Yelena Cheporko, et al.
The Journal of Biological Chemistry|March 14, 2002
Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptorZhan-Guo Gao, Aishe Chen, Dov Barak, et al.
Bioorganic & Medicinal Chemistry|November 4, 2005
Synthesis of hypermodified adenosine derivatives as selective adenosine A3 receptor ligandsLiesbet Cosyn, Zhan-Guo Gao, Philippe Van Rompaey, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2021
Structure activity relationship of 3-nitro-2-(trifluoromethyl)-2H-chromene derivatives as P2Y<sub>6</sub> receptor antagonistsYoung-Hwan Jung, Shanu Jain, Varun Gopinatth, et al.
Current Topics in Medicinal Chemistry|April 14, 2004
Molecular recognition at purine and pyrimidine nucleotide (P2) receptorsKenneth A Jacobson, Stefano Costanzi, Michihiro Ohno, et al.
Journal of Medicinal Chemistry|November 12, 2009
Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groupsArijit Das, Hyojin Ko, Lauren E Burianek, et al.
Pharmacological Research|July 3, 2010
Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([(125)I]MRS2500)Philippe Ohlmann, Sonia de Castro, Garth G Brown, et al.
Chemical Communications (Cambridge, England)|January 6, 2004
Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modelingStefano Moro, Francesca Deflorian, Giampiero Spalluto, et al.
Pageof 60

Showing results (261-270 of 599) with videos related to

Sort By:
Pageof 60
Experimental Neurology|April 15, 2020
Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic strokePranay Srivastava, Chunxia G Cronin, Victoria L Scranton, et al.
Purinergic Signalling|June 6, 2008
Synthesis and pharmacological characterization of [(125)I]MRS1898, a high-affinity, selective radioligand for the rat A(3) adenosine receptorZhan-Guo Gao, Bao Teng, Haitao Wu, et al.
Biochemical Pharmacology|August 31, 2006
Uridine-5'-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarctSmadar Yitzhaki, Asher Shainberg, Yelena Cheporko, et al.
The Journal of Biological Chemistry|March 14, 2002
Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptorZhan-Guo Gao, Aishe Chen, Dov Barak, et al.
Bioorganic & Medicinal Chemistry|November 4, 2005
Synthesis of hypermodified adenosine derivatives as selective adenosine A3 receptor ligandsLiesbet Cosyn, Zhan-Guo Gao, Philippe Van Rompaey, et al.
Bioorganic & Medicinal Chemistry Letters|April 8, 2021
Structure activity relationship of 3-nitro-2-(trifluoromethyl)-2H-chromene derivatives as P2Y<sub>6</sub> receptor antagonistsYoung-Hwan Jung, Shanu Jain, Varun Gopinatth, et al.
Current Topics in Medicinal Chemistry|April 14, 2004
Molecular recognition at purine and pyrimidine nucleotide (P2) receptorsKenneth A Jacobson, Stefano Costanzi, Michihiro Ohno, et al.
Journal of Medicinal Chemistry|November 12, 2009
Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groupsArijit Das, Hyojin Ko, Lauren E Burianek, et al.
Pharmacological Research|July 3, 2010
Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([(125)I]MRS2500)Philippe Ohlmann, Sonia de Castro, Garth G Brown, et al.
Chemical Communications (Cambridge, England)|January 6, 2004
Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modelingStefano Moro, Francesca Deflorian, Giampiero Spalluto, et al.
Pageof 60